Contents
Contents
At the Raleigh ENT device reuse criminal trial, the government proved that a physician reused single-use surgical devices across patients and falsified records to justify Medicare billing. The Justice Department’s account of the criminal trial connects what happened in the treatment room with what the practice told patients and Medicare auditors. For an insider, the telling evidence is the distance between the devices coming through the door, the procedures going out as bills and the paperwork produced when someone questioned them.
The physician operated Greater Carolina Ear, Nose, and Throat, with offices in Raleigh, Lumberton and Rockingham, North Carolina. The criminal trial examined her use of the Entellus XprESS device for balloon sinuplasty, an in-office procedure to treat chronic sinusitis.
The device was intended for one use on one patient. According to the Justice Department’s trial account, the physician instead reused devices on multiple patients without telling them. The devices came into contact with blood and other bodily fluids, creating a risk that material from one patient would reach another patient’s sinuses.
The purchase history makes the practice concrete. Between 2011 and the end of 2017, the physician performed 1,555 balloon sinuplasty surgeries on 919 Medicare patients. Between 2012 and 2017, she obtained at most 36 new Entellus devices. At trial, she admitted that she had enough money to buy a new device for every patient and chose not to.
Medicare paid her millions. She chose to reuse the devices, and the patients were not told what she had chosen for them. A purchasing employee could see the orders for new devices. A clinical employee could see the same instrument return to use. The criminal case joined those parts of the business to the procedures billed to Medicare.
The practice promoted surgery as a free treatment. The Justice Department reported that trial evidence showed employees marketing balloon sinuplasty as a “sinus spa” and encouraging patients to come in for the free treatment, even though they might not need it.
The offer to the patient and the bill to the government told different stories. Between 2014 and 2018, the physician billed Medicare more than $46 million for balloon sinuplasty. The release says she netted more than $4.79 million from Medicare for those surgeries during that period.
The free offer encouraged patients to come in. Reusing the devices avoided buying a new one for each patient. Falsifying medical records helped defend the resulting bills. Those decisions belonged to different parts of the practice, but they served the same business.
The criminal case also exposed a second deception, in the files offered to justify payment. The Justice Department reported that the physician and her staff falsified medical records and forged patient signatures when Medicare auditors examined the practice.
For someone who worked in the office, the discrepancy may be familiar before its financial importance is clear: a signature the patient never gave, or a medical record changed to support a procedure already billed. That knowledge explains why the paperwork looks complete even when it does not describe what happened.
This criminal trial showed how the evidence fits together: device purchases, repeated use, patient promotion, Medicare billing, altered records and the physician’s own admission about buying replacements.
A 2020 review in the Journal of Forensic and Investigative Accounting, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains why an investigation has to follow the request for government money. Its discussion of the False Claims Act connects a false claim to knowledge, payment and the records used to support it.
That perspective gives the clinic’s records a purpose beyond counting procedures. We examine how what the employee saw connects to what the practice billed, and how the documents show who understood the difference. A clinical employee’s knowledge of a reused device and a billing employee’s knowledge of an altered file show the same claim from different directions.
The Justice Department’s announcement also identified a separate whistleblower case against the physician and Greater Carolina Ear, Nose, and Throat.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
Some single-use devices can be reprocessed under Food and Drug Administration requirements. The regulated reprocessing industry takes responsibility for preparing a used device for another use, with manufacturing obligations attached to that work.
The Food and Drug Administration’s 2005 compliance policy treated firms and hospitals reprocessing single-use devices as manufacturers. It placed quality systems, medical-device reporting, registration and labeling among their responsibilities.
In the Raleigh practice, the trial account described a physician repeatedly using the devices across patients and withholding that information from them. The person deciding to use the instrument again is a central part of the story.
The government alleged that The Prometheus Group instructed providers to reuse devices across patients, while the Raleigh physician admitted at her criminal trial that she chose not to buy new devices for every patient.
If you saw instruments reused across patients or records changed to defend Medicare bills, speak to one of our Whistleblower Experts about what you saw. We build the case with you, bring in medical device fraud whistleblower lawyers who understand clinic billing and device reuse, and stay beside you through the pursuit of a recovery.